Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918246 | Radiotherapy and Oncology | 2014 | 7 Pages |
Abstract
IMRT was estimated to have a modest long term advantage over 3DCRT in terms of both improved effectiveness and reduced cost. This result was reliant on clinical judgement and interpretation of the existing literature, but provides quantitative guidance on the cost effectiveness of IMRT whilst long term trial evidence is awaited.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hannah E. Carter, Andrew Martin, Deborah Schofield, Gillian Duchesne, Annette Haworth, Colin Hornby, Mark Sidhom, Michael Jackson,